Periodontal Treatment Market Share Analysis Report, 2023-2032
According to Nova one advisor, the global periodontal treatment market size was valued at USD 8.6 billion in 2022 and is predicted to be worth USD 19.2 billion by 2032, with a CAGR of 5.9% from 2023 to 2032.
Periodontal Treatment Market Introduction
Periodontal ailments are normally the end result of infections of the gums and bone that surround and assist the teeth. In its early stage, referred to as gingivitis, the gums could become swollen and red, and also bleed. In the extra serious form, known as periodontitis, the gums could pull away from the teeth, bone could be lost, and the enamel could loosen or even fall out. Periodontal disorder primarily affects adults. Periodontal disorder and enamel decay are the two largest threats to dental health.
Periodontal disorder could increase the chances of conditions such as stroke, coronary heart disease, diabetes, and respiratory diseases. Untreated, these could lead to enamel extraction. It is highly necessary to deal with these disorders. If a person begins early, it could prevent invasive remedies in the long run.
The goal of periodontal therapy is to remove plaque, biofilm, and tartar from the tooth surface and create a healthy environment. Treatment can be surgical periodontal treatment or non-surgical periodontal therapy. Optimal treatment depends on the patient, localization, and systemic factors.
The California Dental Association (CDA) estimates that 3 out of 4 adults have some form of gum disease. This includes gum recession. Periodontitis is advanced gingivitis. It starts with the buildup of bacteria and plaque on the gums and teeth. Over time, plaque build-up could damage gums and cause teeth to fall out. In severe cases, pockets could form between the teeth and gums. This creates a breeding ground for even more bacteria and plaque to form.
Some of the prominent players in the Periodontal treatment Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global periodontal treatment market.
By Region
Chapter 1. Introduction
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Periodontal Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Periodontal Treatment Market Analysis and Forecast, 2017–2032
4.4.1. Market Revenue Projections
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Key Industry Events (mergers & acquisitions, product launches, partnerships, etc.)
5.3. Overview on types and causes of Periodontal Disease
5.4. Outlook of Major Products used in Surgical and Non-surgical Treatment
5.5. Covid-19 Pandemic Impact on the Industry
6. Global Periodontal Treatment Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment Type, 2017–2032
6.3.1. Non-surgical Treatment
6.3.1.1. Scaling & Root Planning
6.3.1.2. Antibiotics
6.3.1.2.1. Systemic Antibiotics
6.3.1.2.2. Local Antibiotics
6.3.2. Surgical Treatment
6.3.2.1. Pocket Reduction Surgery
6.3.2.2. Soft Tissue Grafts
6.3.2.3. Bone Grafts
6.3.2.4. Others
6.4. Market Attractiveness Analysis, by Treatment Type
7. Global Periodontal Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2032
7.3.1. Hospitals
7.3.2. Dental Clinics
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Periodontal Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Periodontal Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Treatment Type, 2017–2032
9.2.1. Non-surgical Treatment
9.2.1.1. Scaling & Root Planning
9.2.1.2. Antibiotics
9.2.1.2.1. Systemic Antibiotics
9.2.1.2.2. Local Antibiotics
9.2.2. Surgical Treatment
9.2.2.1. Pocket Reduction Surgery
9.2.2.2. Soft Tissue Grafts
9.2.2.3. Bone Grafts
9.2.2.4. Others
9.3. Market Value Forecast, by End-user, 2017–2032
9.3.1. Hospitals
9.3.2. Dental Clinics
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2032
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Treatment Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Periodontal Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment Type, 2017–2032
10.2.1. Non-surgical Treatment
10.2.1.1. Scaling & Root Planning
10.2.1.2. Antibiotics
10.2.1.2.1. Systemic Antibiotics
10.2.1.2.2. Local Antibiotics
10.2.2. Surgical Treatment
10.2.2.1. Pocket Reduction Surgery
10.2.2.2. Soft Tissue Grafts
10.2.2.3. Bone Grafts
10.2.2.4. Others
10.3. Market Value Forecast, by End-user, 2017–2032
10.3.1. Hospitals
10.3.2. Dental Clinics
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2032
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Treatment Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Periodontal Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment Type, 2017–2032
11.2.1. Non-surgical Treatment
11.2.1.1. Scaling & Root Planning
11.2.1.2. Antibiotics
11.2.1.2.1. Systemic Antibiotics
11.2.1.2.2. Local Antibiotics
11.2.2. Surgical Treatment
11.2.2.1. Pocket Reduction Surgery
11.2.2.2. Soft Tissue Grafts
11.2.2.3. Bone Grafts
11.2.2.4. Others
11.3. Market Value Forecast, by End-user, 2017–2032
11.3.1. Hospitals
11.3.2. Dental Clinics
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2032
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Treatment Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Periodontal Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment Type, 2017–2032
12.2.1. Non-surgical Treatment
12.2.1.1. Scaling & Root Planning
12.2.1.2. Antibiotics
12.2.1.2.1. Systemic Antibiotics
12.2.1.2.2. Local Antibiotics
12.2.2. Surgical Treatment
12.2.2.1. Pocket Reduction Surgery
12.2.2.2. Soft Tissue Grafts
12.2.2.3. Bone Grafts
12.2.2.4. Others
12.3. Market Value Forecast, by End-user, 2017–2032
12.3.1. Hospitals
12.3.2. Dental Clinics
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2032
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Treatment Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Periodontal Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Treatment Type, 2017–2032
13.2.1. Non-surgical Treatment
13.2.1.1. Scaling & Root Planning
13.2.1.2. Antibiotics
13.2.1.2.1. Systemic Antibiotics
13.2.1.2.2. Local Antibiotics
13.2.2. Surgical Treatment
13.2.2.1. Pocket Reduction Surgery
13.2.2.2. Soft Tissue Grafts
13.2.2.3. Bone Grafts
13.2.2.4. Others
13.3. Market Value Forecast, by End-user, 2017–2032
13.3.1. Hospitals
13.3.2. Dental Clinics
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2032
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Treatment Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share/Ranking Analysis, by Company, (2021)
14.3. Company Profiles
14.3.1. 3M
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. AMD Lasers, Inc.
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. ASA Dental S.p.A.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Biolase, Inc.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Carl Martin GmbH
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Danaher
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Dentsply Sirona
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Deppeler SA
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Karl Schumacher
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Medtronic
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
14.3.11. Novartis AG
14.3.11.1. Company Overview
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
14.3.12. Pfizer, Inc.
14.3.12.1. Company Overview
14.3.12.2. Product Portfolio
14.3.12.3. SWOT Analysis
14.3.12.4. Strategic Overview
14.3.13. Planmeca Oy
14.3.13.1. Company Overview
14.3.13.2. Product Portfolio
14.3.13.3. SWOT Analysis
14.3.13.4. Strategic Overview
14.3.14. Steris-Hu-Friedy
14.3.14.1. Company Overview
14.3.14.2. Product Portfolio
14.3.14.3. SWOT Analysis
14.3.14.4. Strategic Overview
14.3.15. Straumann AG
14.3.15.1. Company Overview
14.3.15.2. Product Portfolio
14.3.15.3. SWOT Analysis
14.3.15.4. Strategic Overview
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers